Your browser doesn't support javascript.
loading
Aß1-6A2V(D) peptide, effective on Aß aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.
Diomede, Luisa; Zanier, Elisa R; Moro, Federico; Vegliante, Gloria; Colombo, Laura; Russo, Luca; Cagnotto, Alfredo; Natale, Carmina; Xodo, Federica Marta; De Luigi, Ada; Mosconi, Michele; Beeg, Marten; Catania, Marcella; Rossi, Giacomina; Tagliavini, Fabrizio; Di Fede, Giuseppe; Salmona, Mario.
Afiliação
  • Diomede L; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy. luisa.diomede@marionegri.it.
  • Zanier ER; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Moro F; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Vegliante G; Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Colombo L; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Russo L; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Cagnotto A; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Natale C; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Xodo FM; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • De Luigi A; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Mosconi M; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Beeg M; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy.
  • Catania M; Neurology V - Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, Milan, Italy.
  • Rossi G; Neurology V - Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, Milan, Italy.
  • Tagliavini F; Neurology V - Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, Milan, Italy.
  • Di Fede G; Neurology V - Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, Milan, Italy.
  • Salmona M; Department of Molecular Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, Milan, Italy. mario.salmona@marionegri.it.
Mol Psychiatry ; 28(6): 2433-2444, 2023 06.
Article em En | MEDLINE | ID: mdl-37198260

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Lesões Encefálicas Traumáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Lesões Encefálicas Traumáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Humans Idioma: En Revista: Mol Psychiatry Assunto da revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália